SNP array analysis of leukemic relapse samples after allogeneic hematopoietic stem cell transplantation with a sibling donor identifies meiotic recombination spots and reveals possible correlation with the breakpoints of acquired genetic aberrations Allogeneic hematopoietic stem cell transplantation (HSCT) with a sibling donor is commonly used for treating hematologic malignancies. 1 Although this procedure is frequently curative, a proportion of the patients eventually suffers a relapse of the original malignancy. 1 Leukemogenesis is associated with acquired genetic aberrations caused by various mechanisms including induction of double-stranded DNA breaks by DNA toposiomerase II poisons followed by non-homologous end joining, recombination between homologous sequences and illegitimate V(D)J recombination. 2 It has been hypothesized that neoplasia-associated breakpoints may correlate with the breakpoints of meiotic events, that is, some parts of the genome are more prone to both meiotic and somatic rearrangements; however, this remains controversial. [3] [4] [5] During the last five years, numerous studies have used singlenucleotide polymorphism (SNP) array analysis to investigate genetic abnormalities in hematologic malignancies, including paired diagnostic and relapse samples. 6 To the best of our knowledge, however, the particular scenario of a relapse occurring after allogeneic HSCT with a sibling donor has not been addressed with this technique. In such cases, the bone marrow consists of a mixture of the patient-derived leukemic cells and the donor-derived normal hematopoietic cells, displaying different degrees of chimerism depending on the proportion of leukemic cells. In the present study, we have investigated hematologic malignancies that relapsed after allogeneic HSCT with a sibling donor, and we here provide examples and discuss the particular properties of these samples in terms of SNP array analysis. Furthermore, we have, for the first time, investigated whether the breakpoints of acquired leukemia-associated genetic abnormalities and meiotic recombination events are correlated in a single individual genome.
The study included six cases of relapsed hematologic malignancies after HSCT with a sibling donor, comprising one acute myeloid leukemia M0, two acute myeloid leukemia M5, two myelodysplastic syndromes and one chronic myeloid leukemia. DNA was extracted according to standard methods from bone marrow samples obtained at relapse. In addition, a dilution series of a mixture of peripheral blood samples from two unrelated healthy individuals was prepared in ratios of 1:9, 2:8, 3:7, 4:6 and 5:5. SNP array analysis was performed using the Illumina 1M-duo bead Infinium BD BeadChip platform (Illumina, San Diego, CA, USA) as previously described. 7 Expected B-allele frequency (BAF) values for each combination of genotypes in two mixed cell populations were calculated using the formula
where B is the number of B alleles in the respective cell population, p is the frequency of cell population 1, and L is the number of alleles in the respective cell population. Expected BAF values were calculated for mixtures of two samples in different ratios for genomic segments having two identical homologs, one identical homolog and no identical homologs (Supplementary Figure 1A) . Expected BAF values were also calculated for each of the above allele combinations if one of the cell populations harbored loss of one chromosome copy, gain of one copy or a uniparental isodisomy (Supplementary Figures 1A-D) . Somatic and meiotic breakpoints were determined by visual inspection of logR ratios and BAF values.
Chimerism is detectable with SNP array analysis because chimeric samples will display aberrant BAF values, that is, skewed ratios between the two alleles that vary depending on the proportion of the two samples. We calculated expected BAF values and confirmed them experimentally by SNP array analysis of DNA from two unrelated healthy individuals mixed in different proportions (Figure 1a, Supplementary Figure 1A) . We then calculated expected BAF values for a mixture of DNA from two siblings. In the latter scenario, calculations are complicated by the fact that the individuals are closely related. Whether a specific chromosomal segment is identical or not in two siblings depends on the recombination and the independent assortment of homologs that occurred in the first meiotic divisions. There are three possible combinations: (a) for B25% of the genomes, both haplotypes are identical, that is, the same homolog was inherited from both parents; (b) for B50% of the genomes one haplotype is identical, that is, the same homolog was inherited from one of the parents but not from the other; and (c) for B25% of the genomes none of the haplotypes are identical, that is, the siblings inherited different Letters to the Editor homologs from both parents. Hence, three different patterns of BAF values, corresponding to the three possible allele combinations, will be seen across the genome if a mixture of DNA from two siblingsFsuch as relapse samples obtained after HSCT with a sibling donorFis analyzed with SNP array (Figure 1b,  Supplementary Figure 1A) . This deviates substantially from the results seen in a normal sample and may be interpreted as poor quality data if unrecognized, in particular as it also may give rise to low call rates, that is, the proportion of SNPs that could be genotyped by the software. In the present investigation, the chimeric samples displayed call rates of 0.89-0.97, which is lower than the 0.98-0.99 usually obtained with these arrays in our facility (data not shown). Hence, to avoid discarding or reanalyzing samples, one should be aware of the specific BAF values expected in leukemic relapses occurring after HSCT.
Meiotic recombination is a strictly regulated process that takes place during the first meiotic division and that usually occurs at least once for each chromosomal pair, more frequently in the socalled meiotic hotspots. 8 Both meiotic recombination and the formation of acquired structural rearrangements in cancer cells involve a step of ligating double-stranded DNA breaks, and it has therefore been hypothesized that the positions where meiotic and somatic events occur may overlap.
3-5 However, Hagstrom et al. 5 reported no correlation between the positions of acquired 13q abnormalities in retinoblastomas and known meiotic hotspots. In contrast, Howarth et al. 3 found that 5q breakpoints in colorectal cancer correlated with regions of higher meiotic recombination rates. Furthermore, Murphy et al. 4 reported that parts of the genome that frequently have been involved in chromosomal rearrangements during speciation are also more commonly targeted during tumor evolution and speculated that meiotic and somatic chromosome instability may hence be linked. However, to the best of our knowledge, no study of the possible correlation between meiotic and somatic breakpoints in a single individual genome has ever been reported. The present series of relapse samples provided us with the opportunity to address this issue because SNP array analysis of relapse samples after HSCT with a sibling donor enable simultaneous mapping of both meiotic and somatic events (Supplementary Tables 1, 2) . A total of 26 mitotic breakpoints were detected in four of the cases (Supplementary Table 1 Letters to the Editor of these 26 mitotic breakpoints showed that no meiotic recombination had occurred (Supplementary Table 1, Figure 2 ). However, for three (12%) breakpoints, the allele combination changed at the leukemic breakpoint, that is, the latter appeared to occur in the same spot as a meiotic recombination (Figure 2 , Supplementary Table 1 ). The observed overlap of meiotic and somatic breakpoints was statistically significant as determined by permutation analysis, in which we randomly sampled the observed number of somatic alterations and assessed whether these colocalized within 40 kb of the observed meiotic breakpoints (P ¼ 0.0079 and Po1 Â 10 À5 for case 1 and case 4, respectively; 100 000 permutations). This implies that some regions of meiotic recombination are more prone to subsequent double-stranded breaks. However, two notes of caution should be applied in interpreting these results. First, although we have used high-resolution arrays, we can only pin down the breakpoint region to approximately 10-20 kb depending on the density of SNPs, allowing for close meiotic and somatic breakpoints to appear identical. Second, we cannot determine in which meiosis the recombination occurred. Nevertheless, our data suggest that regions of meiotic recombination may be more prone to acquire chromosomal rearrangements.
